Percutaneous pulmonary valve implantation in grown-up congenital heart disease patients: Insights from the Zurich experience

2017 ◽  
Vol 31 (2) ◽  
pp. 251-260 ◽  
Author(s):  
Luca Oechslin ◽  
Roberto Corti ◽  
Matthias Greutmann ◽  
Oliver Kretschmar ◽  
Oliver Gaemperli
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

scholarly journals Percutaneous Pulmonary Valve Implantation-Associated Ventricular Tachycardia in Congenital Heart Disease

2016 ◽  
Vol 29 (6) ◽  
pp. 639-645 ◽  
Author(s):  
Robert W. Loar ◽  
Athar M. Qureshi ◽  
Christina Y. Miyake ◽  
Santiago O. Valdes ◽  
Jeffrey J. Kim ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Ventricular Tachycardia ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

Percutaneous Pulmonary Valve Implantation in a Bangladeshi Center: A Case Series

2020 ◽  
Vol 28 (1) ◽  
pp. 1-6
Author(s):  
Fatema Nurun Nahar ◽  
Jufan Mansur Al ◽  
Shubert Stephan ◽  
Hossain Mir Mahmud
Keyword(s):  
Heart Disease ◽  
Pulmonary Artery ◽  
Right Ventricle ◽  
Pulmonary Valve ◽  
Case Series ◽  
Military Hospital ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

INTRODUCTION Incidence of congenital heart disease is 25 per thousand live birth in Bangladesh which is much higher than other countries. Tetralogy of Fallot, the commonest cyanotic heart disease (5%) and some other complex diseases with right ventricular outflow tract abnormality demand surgical correction and revision in many occasions including percutaneous intervention. As a resource constraint country, it was a difficult task to introduce percutaneous pulmonary valve implantation (PPVI) with MelodyTM. However, it was started on 12th December 2012 in Combined Military Hospital Dhaka, Bangladesh and cases performed till October 2019 were included in this series. METHODS Retrospective analysis of six cases who had PPVI with MelodyTM in Combined Military Hospital, Bangladesh. Patient with dysfunctional conduit between right ventricle (RV) and pulmonary artery causing (a) Symptoms of exceptional dyspnoea of various grade (NYHA II,III, IV) (b) RVEVD >150 ml/m2 ±regurgitant fraction >40% (c) RVOT peak instantaneous gradient > 30 mm Hg. (d) RV dysfunction (RVEF<40%) were accepted for the procedure and outcome were analyzed. RESULTS Mean age was 9.56 ± 2.96 years, weight was 28.75 ± 8.61 kg, height was 137.5 ± 17.52 cm. Mean age at surgery was 4.25 ± 2.72 years. Female were 66.66%. Aortic homograft was used in 66.66% cases. Eighteen mm Ensemble was used in four (66.66%) cases and 20 mm and 22 mm in one each. Immediate result was excellent with no residual PS in two cases and negligible residual flow acceleration across pulmonary valve in four cases. No PR seen in all except one. One patient developed Bacterial endocarditis after 3 years and was treated. CONCLUSION Aim of PPVI is to prolong the life expectancy of conduits which were placed surgically from right ventricle to pulmonary artery. In our case series, we found that Melody valve is functioning well without any complications like infective endocarditis or stent fracture. KEYWORDS PPVI, MelodyTM, RVOT, Outcome

scholarly journals Right ventricular restoration during pulmonary valve implantation in adults with congenital heart disease☆

2006 ◽  
Vol 29 ◽  
pp. S279-S285 ◽  
Author(s):  
Alessandro Frigiola ◽  
Alessandro Giamberti ◽  
Massimo Chessa ◽  
Marisa Di Donato ◽  
Raul Abella ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Right Ventricular ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Valve Implantation ◽  
Ventricular Restoration ◽  
Pulmonary Valve Implantation

scholarly journals Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation

2014 ◽  
Vol 148 (5) ◽  
pp. 2253-2259 ◽  
Author(s):  
Sophie Malekzadeh-Milani ◽  
Magalie Ladouceur ◽  
Laurence Iserin ◽  
Damien Bonnet ◽  
Younes Boudjemline
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Valve Implantation ◽  
Pulmonary Valve Implantation

scholarly journals Percutaneous Pulmonary Valve Placement

2015 ◽  
Vol 42 (3) ◽  
pp. 195-201 ◽  
Author(s):  
Athar M. Qureshi ◽  
Lourdes R. Prieto
Keyword(s):  
Congenital Heart Disease ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Pulmonary Stenosis ◽  
Clinical Status ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Placement ◽  
Valve Implantation ◽  
Further Development ◽  
Percutaneous Pulmonary Valve

Patients with congenital heart disease and pulmonary valve disease need multiple procedures over their lifetimes to replace their pulmonary valves. Chronic pulmonary stenosis, regurgitation, or both have untoward effects on ventricular function and on the clinical status of these patients. To date, all right ventricle–pulmonary artery conduits have had relatively short lifespans. Percutaneous pulmonary valve implantation, although relatively new, will probably reduce the number of operative procedures that these patients will have to undergo over a lifetime. Refinement and further development of this procedure holds promise for the extension of this technology to other patient populations.

scholarly journals Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives

2019 ◽  
Vol 15 (4) ◽  
pp. 262-273 ◽  
Author(s):  
Bart W. Driesen ◽  
Evangeline G. Warmerdam ◽  
Gert-Jan Sieswerda ◽  
Folkert J. Meijboom ◽  
Mirella M.C. Molenschot ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Congenital Heart ◽  
Pulmonary Valve ◽  
Anatomical Variations ◽  
Current Status ◽  
Future Perspectives ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Procedural Success ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve

Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

Sign in / Sign up

Export Citation Format

Share Document